Tiffany, Kors to Re...
Services: Diversified Services
Myriad Genetics Inc. (MYGN: NASDAQ)
$31.43 -0.76 | -2.36%
05/24/13 - 04:00 PM ET
Insider Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Net Insider Transaction | -72,350 | -62,218 | -70,170 | 7,504 | -2,628 | 5,324 | 0 |
| Shares Bought | 462,950 | 515,982 | 651,337 | 253,711 | 246,079 | 110,724 | 50,357 |
| Shares Sold | 535,300 | 578,200 | 721,507 | 246,207 | 248,707 | 105,400 | 50,357 |
Institutional Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Total Shares Held | 75.72M | 75.38M | 73.08M | 72.89M | 73.49M | 71.66M | 73.80M |
| Shares Bought | 14.76M | 13.82M | 11.19M | 8.01M | 8.93M | 8.48M | 10.98M |
| Shares Sold | 10.26M | 10.21M | 10.49M | 12.20M | 10.51M | 10.07M | 12.27M |
Portfolios with MYGN
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ProJoel Greenblatt - Gotham Ca...
- ContributorStocks Rising On Unusual Vo...
- UserDesNews
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- Contributor4 Upgraded, Undervalued Stocks
- Contributor8 Health Care Buys Ahead of...
- ProClovis Capital Management
- ProRS Investment Management
Latest MYGN Headlines from TheStreet
- Stocks to Watch: Cisco, BlackBerry, Macy's 05.15.13 | 05:05 am
- Myriad Genetics To Present At The Bank Of America Merrill Lynch Health Care Conference 05.14.13 | 07:05 am
- Myriad Stock Hits New 52-Week High (MYGN) 05.10.13 | 12:05 pm
- Myriad Rises On Unusually High Volume (MYGN) 05.08.13 | 03:05 pm
- Today's Top Performers In Diversified Services 05.08.13 | 01:05 pm
- Myriad Genetics Reports Third Quarter Fiscal Year 2013 Results 05.07.13 | 04:05 pm
- Myriad Genetics Announces 2013 Analyst And Investor Day 05.02.13 | 04:05 pm
- Myriad To Present New Molecular Data For Patients With Prostate Cancer At The American Urological Association 2013 Annual Meeting 05.02.13 | 07:05 am
- Myriad Genetics To Announce Third Fiscal Quarter 2013 Results On Tuesday, May 7, 2013 04.18.13 | 04:04 pm
- Myriad Adopts RainDance's Thunderstorm Platform For Next-Generation Sequencing Based Hereditary Cancer Panel 04.17.13 | 04:04 pm
Press Releases for MYGN
- Myriad Genetics Receives The "Corporate Spirit Of Giving Award" From The Utah Philanthropy Day Committee - PR Newswire 11.02.11 | 07:11 am
- Rules-Based Medicine Reaches A Significant Milestone In Companion Diagnostic Program With Roche - PR Newswire 05.25.11 | 04:05 pm
- Rules-Based Medicine, Inc. (RBM) Partners With Institut Pasteur To Boost Innovation In Translational Research - PR Newswire 05.12.11 | 08:05 am
Partner Headlines for MYGN
- US judges cast doubts on DNA patents - Financial Times 04.15.13 | 06:04 pm
- Myriad Says US Supreme Court to Hear Isolated DNA Patent Case - Benzinga 11.30.12 | 04:11 pm
- Testing, Testing: Analyst Kevin DeGeeter On 5 Good Bets In Cancer Diagnostics - Seeking Alpha 11.30.12 | 09:11 am
- Myriad Genetics - Momentum - Zacks 11.20.12 | 01:11 am
- Stocks Tack On More Gains; Cirrus Logic Retakes 200-Day Line - Investor's Business Daily 11.19.12 | 01:11 pm
- Parexel International Leads Medical Research Group - Investor's Business Daily 11.16.12 | 06:11 pm
- Leggett, Sherwin-Williams, DaVita Buck Weak Market - Investor's Business Daily 11.15.12 | 06:11 pm
- Strong 1Q from Myriad, Guidance Up - Analyst Blog - Zacks 11.06.12 | 09:11 am
- Stocks Improve In Late Trade; Nationstar Pares Losses - Investor's Business Daily 11.05.12 | 03:11 pm
- Myriad Remains Neutral - Analyst Blog - NASDAQ 09.21.12 | 07:09 pm
